Skip to main content
OpenTrials

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,360 public trials 356 recruiting studies
Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Recruiting

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

NCT06996652

Conditions
Mental Disorders, Metabolic Diseases, Nervous System Diseases, +8 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • Yale Medicine North Haven, Connecticut, United States
  • Parkinson's Disease & Movement Disorders Center of Boca Raton Boca Raton, Florida, United States
View all 19 locations
View Trial Details
Recruiting

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

NCT06569147

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Yale University New Haven, Connecticut, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

NCT07660614

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University Hospital Schleswig-Holstein, Campus Lübeck Lübeck, Germany
  • Istituto Neurologico "Carlo Besta" Milan, Italy
  • AOU Città della Salute e della Scienza di Torino Torino, Italy
  • Universitair Medisch Centrum Utrecht Utrecht, Netherlands
View Trial Details
Recruiting

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

NCT07223203

Conditions
Amyloidosis, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, Metabolic Diseases, +7 more
Locations
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Chicago, Illinois, United States
  • Clinical Trial Site Baltimore, Maryland, United States
  • Clinical Trial Site Boston, Massachusetts, United States
View all 48 locations
View Trial Details
Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT07052903

Conditions
Amyloidosis, Cardiomyopathies, Cardiovascular Diseases, +5 more
Locations
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Stanford, California, United States
  • Clinical Trial Site Norwich, Connecticut, United States
  • Clinical Trial Site Washington D.C., District of Columbia, United States
View all 251 locations
View Trial Details

Related conditions